Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy
AIDS Behav. 2011-10-09; 16(7): 2082-2090
DOI: 10.1007/s10461-011-0054-4
Lire sur PubMed
1. AIDS Behav. 2012 Oct;16(7):2082-90.
Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users
seeking treatment over an 11-year period and harm reduction policy.
Fatseas M(1), Denis C, Serre F, Dubernet J, Daulouède JP, Auriacombe M.
Author information:
(1)Laboratoire de Psychiatrie/CNRS USR 3413, Université Bordeaux Segalen, 121 rue
de la Béchade, Bordeaux, France, Europe.
Our purpose was to assess change in HIV and HCV prevalence and risk-taking
behaviors among IDUs over a period of time that included changes in French Public
Health policy. Risk behavior and biological testing for serostatus were collected
from cross-sectional samples of yearly new requests for opiate dependence
treatment in Aquitaine, France between 1994 and 2004 (n = 648). Coincident
declines in injection equipment sharing and HIV prevalence among injectors were
observed, while sexual behavior remained stable. There was a decline in HCV
prevalence that was not significant among injectors. After controlling for
potential confounding variables, participants enrolled after 1995 were less
likely to share injection material and those enrolled after 1999 were less likely
to share spoons. Our findings give evidence for behavioral and seroprevalence
changes among IDUs over a period of time that included changes in needle access
policy.
DOI: 10.1007/s10461-011-0054-4
PMID: 21983799 [Indexed for MEDLINE]